Super Seal Oil Complex
Natural health product licensed in Canada
- Licence holder
- Canada Optimal Nature Inc.
- NPN or DIN-HM
- 80132413
- Status
- Active licence
- Licence date
- 11 July 2024
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 4,000 mg Potency : 24 % Flavonoid glycosides | 80 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Lécithine Source : Glycine max - Graine | 20 mg | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 10 mg AT | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Graine Extract : Matériel brut sec Dry plant equivalent : 500 mg Potency : 85 % Oligomeric proanthocyanidins | 20 mg | Not calculated |
| Huile de phoque Source : Pagophilus groenlandicus - petit lard Potency : 25 mg Docosapentaenoic acid | Not specified | Not calculated |
| Huile de phoque Source : Phoca vitulina - petit lard Potency : 25 mg Docosapentaenoic acid | Not specified | Not calculated |
| Huile de phoque Source : Pagophilus groenlandicus - petit lard Potency : 45 mg Docosahexaenoic acid | 500 mg | Not calculated |
| Huile de phoque Source : Phoca vitulina - petit lard Potency : 45 mg Docosahexaenoic acid | 500 mg | Not calculated |
| Allium sativum Source : Allium sativum - Bulbe Extract : Matériel brut sec Dry plant equivalent : 200 mg Potency : 5 % Alliin | 20 mg | Not calculated |
| Huile de phoque Source : Pagophilus groenlandicus - petit lard Potency : 35 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de phoque Source : Phoca vitulina - petit lard Potency : 35 mg Eicosapentaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Eau, Cire d'abeille, Glycérine, Gélatine, Oxyde de fer noir, Caramel
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids for the maintenance of good health. Used in Herbal Medicine to help reduce elevated blood lipid levels (hyperlipidemia) and maintain cardiovascular health in adults. Helps to enhance cognitive function and/or memory in adults. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132413
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.